FLGT
Fulgent Genetics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$19.73
+0.41%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.02x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.14x
- Net debt / EBITDA
- 0.26x
Liquidity & coverage
- Current ratio
- 6.34x
- Quick ratio
- 6.18x
- Cash ratio
- 3.58x
- Interest coverage
- -504.67x
- EBITDA / interest
- -273.20x
- Working capital
- $383.0M
Cash & dividend
- FCF / debt
- -11.02x
- Cash flow / debt
- -8.88x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026